Azitra (AZTR) Treasury Shares (2022 - 2023)

Azitra (AZTR) posted Treasury Shares of $380657.0 for Q1 2023, down 2.72% on a QoQ basis from $391303.0 in Q4 2022.

Azitra (AZTR) Treasury Shares (2022 - 2023) Analysis & Trends

Azitra's Treasury Shares history runs 2 years deep, the most recent figure standing at $380657.0 for Q1 2023.

Quarterly Treasury Shares changed N/A year-over-year to $380657.0 in Q1 2023, while the trailing twelve-month figure through Mar 2023 was $380657.0 (changed N/A YoY) and the FY2022 annual result came in at $391303.0, changed N/A from the prior year.
Treasury Shares was $380657.0 for Q1 2023 at Azitra, down from $391303.0 in the prior quarter.
Across five years, Treasury Shares topped out at $391303.0 in Q4 2022 and bottomed at $380657.0 in Q1 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Nanobiotix	1,769.80 Bn	1,769.74 Bn	-	259,453.57
2	Akari Therapeutics	1,009.43 Bn	1,009.43 Bn	-	-
3	BeOne Medicines	473.64 Bn	468.85 Bn	1.35 Bn	-
4	Vertex Pharmaceuticals	123.74 Bn	116.49 Bn	2.59 Bn	-
5	Regeneron Pharmaceuticals	71.73 Bn	62.97 Bn	3.31 Bn	34.70 Mn
6	Belite Bio	62.10 Bn	62.10 Bn	-	-
7	Argenx Se	54.68 Bn	49.49 Bn	1.41 Bn	-
8	Alnylam Pharmaceuticals	38.13 Bn	35.12 Bn	959.66 Mn	-
9	Revolution Medicines	36.21 Bn	36.21 Bn	-	5.14 Mn
10	Azitra	2.03 Mn	2.03 Mn	-	-

Download Data